Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epigallocatechin gallate for treatment of cutaneous leishmaniasis
IRCT20180526039848N2Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Dec 2020
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-arm trial of epigallocatechin gallate in cutaneous leishmaniasis (CL), sponsored by Mashhad University of Medical Sciences. Started Dec 2020; status: completed.
02
Drugs
epigallocatechin gallate
03
Conditions
cutaneous leishmaniasis (CL)
Beyond the preview
Go deeper on IRCT20180526039848N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180526039848N2.